journal
https://read.qxmd.com/read/37949435/comparison-of-health-related-quality-of-life-measures-in-asthma-copd-overlap
#21
JOURNAL ARTICLE
Meishan Liu, Xuwen Yang, Ying Wang, Yong Lu, Lirong Liang, Hong Zhang, Kewu Huang
OBJECTIVE: The Asthma Quality of Life Questionnaire (AQLQ) and COPD assessment test (CAT) are used to assess the health status of asthma and chronic obstructive pulmonary disease (COPD), respectively. However, whether these questionnaires are appropriate in patients with asthma-COPD overlap (ACO) has not been reported. This study aimed to evaluate the performance of the AQLQ and CAT in subjects with ACO. METHODS: Subjects were enrolled from two previously described observational studies in Beijing, China...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37934787/characterising-hospitalisation-risk-for-chronic-obstructive-pulmonary-disease-exacerbations-bedside-and-outpatient-clinic-assessments-of-easily-measured-variables
#22
JOURNAL ARTICLE
Joshua Heerema, Sarah Hug, Natasha Bear, Kylie Hill
OBJECTIVE: To identify the characteristics of people with chronic obstructive pulmonary disease (COPD) who require hospitalisation for exacerbations. METHODS: People with COPD were recruited either during hospitalisation or from out-patient respiratory medicine clinics. Hospital admissions were tracked throughout the 5-months recruitment period. For participants who were admitted, hospital readmissions were tracked for at least 30 days following discharge. Participants were grouped as either needing; (i) no hospital admission during the study period (no admission; ø-A), (ii) one or more hospital admissions during the study period but no readmission within 30 days of discharge (no rapid readmission; ø-RR) or (iii) one or more hospital admissions with a readmission within 30 days of discharge (rapid readmission; RR)...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37933757/translation-cross-cultural-adaptation-reliability-and-construct-validity-of-the-brazilian-portuguese-version-of-the-basic-psychological-needs-in-exercise-scale
#23
JOURNAL ARTICLE
Manuela Karloh, Simone G Gavenda, Juliana Araújo, Hellen F Alexandre, Isabela Jcs Silva, Aline A Gulart, Anelise B Munari, Symeon P Vlachopoulos, Thiago S Matias, Anamaria F Mayer
59 patients were included (61% with COPD and 39% with ILD). BPNES factor scores were not significantly different between raters' assessments ( p > 0.05). The internal consistency was 0.70 for autonomy, 0.76 for competence, and 0.80 for relatedness. Inter-rater and test-retest reliability were good to very good for autonomy (ICC = 0.78, 95%CI 0.62-0.87; ICC = 0.75, 95%CI 0.57-0.86, respectively), competence (ICC = 0.81, 95%CI 0.68-0.89; ICC = 0.65, 95%CI 0.43-0.80, respectively), and relatedness (ICC = 0...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37889184/simultaneous-evaluation-of-the-fractional-exhaled-nitric-oxide-and-blood-eosinophil-count-of-t2-high-endotype-in-patients-with-non-cystic-fibrosis-bronchiectasis
#24
JOURNAL ARTICLE
Fengjia Chen, Zhimin Zeng, Xinyan Huang, Yangli Liu
OBJECTIVE: Recently, a type 2 inflammation (T2) high endotype in bronchiectasis was identified. The fraction of exhaled nitric oxide (FeNO) and blood eosinophil count (BEC) are recognized as representative biomarkers of T2 inflammation. Herein, we investigate the clinical characteristics of T2-high endotype in non-cystic fibrosis bronchiectasis patients classified by FeNO and BEC. METHODS: This retrospective study included 164 bronchiectasis patients treated in the First Affiliated Hospital of Sun Yat-sen University from December 2017 to July 2022...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37800633/how-can-the-findings-of-the-emax-trial-on-long-acting-bronchodilation-in-chronic-obstructive-pulmonary-disease-be-applied-in-the-primary-care-setting
#25
REVIEW
Edward M Kerwin, Paul W Jones, Leif H Bjermer, François Maltais, Isabelle H Boucot, Ian P Naya, David A Lipson, Chris Compton, Lee Tombs, Claus F Vogelmeier
This review addresses outstanding questions regarding initial pharmacological management of chronic obstructive pulmonary disease (COPD). Optimizing initial treatment improves clinical outcomes in symptomatic patients, including those with low exacerbation risk. Long-acting muscarinic antagonist/long-acting β2 -agonist (LAMA/LABA) dual therapy improves lung function versus LAMA or LABA monotherapy, although other treatment benefits have been less consistently observed. The benefits of dual bronchodilation in symptomatic patients with COPD at low exacerbation risk, and its duration of efficacy and cost effectiveness in this population, are not yet fully established...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37746859/prevalence-and-assessment-of-frailty-in-interstitial-lung-disease-a-systematic-review-and-meta-analysis
#26
JOURNAL ARTICLE
Angela Weber, Ilena Müller, Annina E Büchi, Sabina A Guler
BACKGROUND: Frailty is a multisystem dysregulation that challenges homeostasis and increases vulnerability towards stressors. In patients with interstitial lung diseases (ILD) frailty is associated with poorer lung function, greater physical impairment, and higher symptom burden. Our understanding of the prevalence of frailty in ILD and consequently its impact on the ILD population is limited. OBJECTIVE AND METHODS: We aimed to systematically review frailty assessment tools and to determine frailty prevalence across different ILD cohorts...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37691169/effect-of-a-pulmonary-rehabilitation-program-combined-with-cognitive-training-on-exercise-tolerance-and-cognitive-functions-among-tunisian-male-patients-with-chronic-obstructive-pulmonary-disease-a-randomized-controlled-trial
#27
JOURNAL ARTICLE
Oussama Tabka, Imen Sanaa, Marwa Mekki, Amal Acheche, Thierry Paillard, Yassine Trabelsi
BACKGROUND: Cognitive impairment has been well described in patients with Chronic Obstructive Pulmonary Disease (COPD) in addition to cardiorespiratory disability. To reduce this impairment, researchers have recommended the use of single or combined exercise training. However, the combined effect of cognitive training (CT) and pulmonary rehabilitation (PR) program on selective cognitive abilities in patients with COPD has not been fully evaluated. Therefore, we aimed to assess the impact of PR combined with CT on 6 minutes walking test (6MWT) and cognitive parameters in Tunisian males' patients with COPD...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37658799/development-and-implementation-of-the-lung-volume-reduction-pulmonary-rehabilitation-tool-to-identify-eligibility-for-lung-volume-reduction-in-people-with-chronic-obstructive-pulmonary-disease-during-pulmonary-rehabilitation
#28
JOURNAL ARTICLE
Sara C Buttery, Parris J Williams, Lisa J Brighton, Craig Batista, Amy Dewar, Lauren Hogg, Karen Ingram, Gemma Korff, Maria Koulopoulou, Helen Lammin, Matthew Maddocks, Lynn McDonnell, Bhavin Mehta, Victoria Meyrick, Lisa Pritchard, Oliver Smith, Puja Trivedi, Rod A Lawson, Nicholas S Hopkinson
BACKGROUND: Completion of pulmonary rehabilitation is recognised in chronic obstructive pulmonary disease (COPD) guidelines as a key opportunity to consider systematically whether a respiratory review to assess potential suitability for a lung volume reduction (LVR) procedure might be appropriate. We describe the development of a simple decision-support tool (the LVR-PR tool) to aid clinicians working in pulmonary rehabilitation, to operationalise this process. METHODS: We took an iterative mixed methods approach, which was partnership-based and involved an initial consensus survey, focus groups and an observational study cohort at multiple pulmonary rehabilitation centres...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37649451/long-term-mechanical-ventilation-state-of-the-evidence-and-future-directions
#29
EDITORIAL
Sunita Mathur, Michael Steiner
No abstract text is available yet for this article.
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37612250/clinical-validation-of-a-wearable-respiratory-rate-device-a-brief-report
#30
JOURNAL ARTICLE
Arik Eisenkraft, Nir Goldstein, Arik Ben Ishay, Meir Fons, Michael Tabi, Anna Danielle Sherman, Roei Merin, Dean Nachman
BACKGROUND: Respiratory rate (RR) is used for the diagnosis and management of medical conditions and can predict clinical changes. Heavy workload, understaffing, and errors related to poor recording make it underutilized. Wearable devices may facilitate its use. METHODS: RR measurements using a wearable photoplethysmography-based monitor were compared with medical grade devices in complementary clinical scenarios: Study one included a comparison to a capnograph in 35 healthy volunteers; Study two included a comparison to a ventilator monitor in 18 ventilated patients; and Study three included a comparison to capnograph in 92 COVID-19 patients with active pulmonary disease...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37606249/the-arrival-ward-requiring-help-by-wheelchair-or-medical-cart-arterial-oxygenation-index-age-albumin-and-neutrophil-count-score-predicting-in-hospital-mortality-in-chinese-patients-with-acute-exacerbations-of-chronic-obstructive-pulmonary-disease
#31
JOURNAL ARTICLE
Dawei Chen, Caimei Chen, Pan Zhang, Feng Zhang, Hao Zhang, Qing Sun, Jian Sun, Yan Tan, Binbin Pan, Xin Wan
BACKGROUND: In this study, we will derive and validate a prognostic tool to predict in-hospital death based on Chinese acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients. METHODS: Independent predictors of in-hospital death were identified by logistic regression analysis and incorporated into a clinical prediction tool. RESULTS: The clinical prediction model was developed with data from 1121 patients and validated with data from 245 patients...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37596992/comorbidity-and-mortality-in-systemic-sclerosis-and-matched-controls-impact-of-interstitial-lung-disease-a-population-based-cohort-study-based-on-health-registry-data
#32
JOURNAL ARTICLE
Malene Knarborg, Charlotte Hyldgaard, Elisabeth Bendstrup, Jesper Rømhild Davidsen, Anders Løkke, Saher Burhan Shaker, Ole Hilberg
OBJECTIVE: This population-based, matched cohort study evaluates the impact of comorbidities on mortality among systemic sclerosis (SSc) patients with and without interstitial lung disease (ILD). METHOD: Patients with a first-time SSc diagnosis between 2002 and 2015 were identified in the Danish National Patient Registry, separated into two cohorts - with ILD (SSc-ILD) and without ILD (non-ILD SSc), and matched 1:4 with controls from the general population on age, sex, residency and marital status...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37585691/the-impact-of-bronchoalveolar-lavage-on-the-diagnosis-of-undifferentiated-interstitial-lung-disease-alongside-a-multidisciplinary-discussion
#33
JOURNAL ARTICLE
Wafa B Khan, Harry M Gallagher, Dilip Jayasimhan, Michael Dray, Catherina L Chang
BACKGROUND AND OBJECTIVE: Cellular analysis of bronchoalveolar lavage (BAL) fluid may aid diagnosis in patients with undifferentiated interstitial lung disease (ILD). The utility of this test in the diagnostic process in conjunction with a multidisciplinary discussion (MDD) is not known. We aim to assess and compare interobserver agreement and diagnostic confidence before and after presenting BAL results in an ILD-MDD. METHODS: Patients undergoing investigations for ILD at Waikato Hospital were recruited...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37564035/changes-in-lung-cancer-staging-and-emergency-presentations-during-the-first-year-of-the-covid-19-pandemic
#34
JOURNAL ARTICLE
Claire Vella, Wadood Parvez, Asif Ashraf, Syed Ajmal, Rajini Sudhir, Sanjay Agrawal, Jonathan Bennett, Muhammad Tufail
Aim : This study retrospectively analyses the impact of the 1st year of the COVID-19 pandemic on route of presentation and staging in lung cancer compared to the 2 years before and after implementation of the Leicester Optimal Lung Cancer Pathway (LOLCP) in Leicester, United Kingdom. Method : Electronic databases and hospital records were used to identify all patients diagnosed with lung cancer in 2018 (pre-LOLCP), 2019 (post-LOLCP), and March 2020-2021 (post-COVID-19 lockdown). Information regarding patient characteristics, performance status, stage, and route of diagnosis was documented and analysed...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37471305/implementation-and-maintenance-of-an-enhanced-pulmonary-rehabilitation-program-in-a-single-centre-an-implementation-study
#35
JOURNAL ARTICLE
Kim van der Braak, Joshua Wald, Catherine M Tansey, Thais Paes, Maria Sedeno, Anne-Marie Selzler, Michael K Stickland, Jean Bourbeau, Tania Janaudis-Ferreira
BACKGROUND: Pulmonary rehabilitation (PR) has major benefits for patients with chronic obstructive pulmonary disease (COPD). An enhanced PR program was developed with a self-management education intervention. The objective of our study was to evaluate the implementation of the enhanced PR program into a single centre. METHODS: Pre-post implementation study consisted of two evaluation periods: immediately after implementation and 18 months later. Guided by the RE-AIM framework, outcomes included: Reach, Effectiveness, Adoption, Implementation and Maintenance ...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37344979/reflecting-on-the-importance-of-theory-informed-qualitative-research-in-people-with-chronic-respiratory-disease-and-their-carers
#36
EDITORIAL
Emma L Giles, Samantha L Harrison
No abstract text is available yet for this article.
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37311772/strategies-to-deliver-smoking-cessation-interventions-during-targeted-lung-health-screening-a-systematic-review-and-meta-analysis
#37
REVIEW
Parris J Williams, Keir Ej Philip, Saeed M Alghamdi, Alexis M Perkins, Sara C Buttery, Michael I Polkey, Anthony A Laverty, Nicholas S Hopkinson
INTRODUCTION: Lung cancer screening presents an important teachable moment to promote smoking cessation, but the most effective strategy to deliver support in this context remains to be established. METHODS: We undertook a systematic review and meta-analysis of smoking cessation interventions delivered during lung health screening, published prior to 20/07/2022 MEDLINE, PsychINFO, CENTRAL, EMBASE, CINAHL and Scopus databases. Two reviewers screened titles, and abstracts, four reviewed each full text using prespecified criteria, extracted relevant data, assessed risk of bias and confidence in findings using the GRADE criteria...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37219417/respiratory-therapies-for-amyotrophic-lateral-sclerosis-a-state-of-the-art-review
#38
REVIEW
Priscila Sales de Campos, Wendy L Olsen, James P Wymer, Barbara K Smith
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative condition noteworthy for upper and lower motor neuron death. Involvement of respiratory motor neuron pools leads to progressive pathology. These impairments include decreases in neural activation and muscle coordination, progressive airway obstruction, weakened airway defenses, restrictive lung disease, increased risk of pulmonary infections, and weakness and atrophy of respiratory muscles. These neural, airway, pulmonary, and neuromuscular changes deteriorate integrated respiratory-related functions including sleep, cough, swallowing, and breathing...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37199317/palliation-end-of-life-care-and-ventilation-withdrawal-in-neuromuscular-disorders
#39
REVIEW
Joanna Elverson, Hayley Evans, Felicity Dewhurst
BACKGROUND/OBJECTIVES: The role of palliative care in the support of patients with neuromuscular disorders (NMDs) is generally recognised in spite of the scarcity of condition-specific evidence in the literature. METHODS: We have focussed specifically on palliative and end-of-life care for patients whose neuromuscular disease has an impact on their respiratory function. Reviewing the literature, we have examined where existing palliative care knowledge can be applied to the specific challenges faced by patients with NMDs, identifying where lessons learnt during the management of one condition may need to be judiciously applied to others...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37192536/symptoms-burden-and-rehabilitation-preference-after-an-episode-of-covid-19-a-patients-survey
#40
JOURNAL ARTICLE
Munyra Alhotye, Enya Daynes, Charlotte Gerlis, Sally J Singh
BACKGROUND: After COVID-19 infection, individuals can experience a variety of symptoms that might require further treatment. Early data showed the value of adapted pulmonary rehabilitation programmes and technology-based interventions. To develop appropriate services, it is important to understand the symptom burden and the preferred mode of rehabilitation delivery. METHODS: Post-hospital discharge (H) and post-community-managed (C) individuals received a follow-up call...
2023: Chronic Respiratory Disease
journal
journal
40578
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.